Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Moss Genomics Inc.: Canadian Company Moss Genomics Announces Agreement to Acquire Ethereum, Appoints Jack Liu as CEO and Director, Private Placement and Option Grant | 386 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 24, 2024) - Moss Genomics Inc. (CSE: MOSS) (the "Company" or "Moss") today announced the appointment of Jack Liu as CEO and a Director of the... ► Artikel lesen | |
Di | MedMira, Inc.: MedMira receives Health Canada approval for its Multiplo Rapid Test for Syphilis and HIV | 336 | ACCESSWIRE | HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo® Rapid... ► Artikel lesen | |
Di | GenSight Biologics S.A.: GenSight Biologics announces a financing for an amount of c. €1.5 million from existing investors | 298 | Business Wire | THIS PRESS RELEASE IS NOT BEING MADE IN AND COPIES OF IT MAY NOT BE DISTRIBUTED OR SENT, DIRECTLY OR INDIRECTLY, INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA
Regulatory News:... ► Artikel lesen | |
Di | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 274 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
Di | Achilles Therapeutics PLC: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca | 268 | GlobeNewswire (Europe) | - Proprietary data and samples from TRACERx and Achilles' Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction -
- Conclusion of Strategic Review -
LONDON... ► Artikel lesen |
Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
---|---|---|---|---|---|---|
ENZO BIOCHEM | 0,715 | 0,09 | +13,27 % | |||
AMGEN | 254,15 | 8,66 | +3,41 % | 2,38 | 14.02.2025 | |
RECORDATI | 50,60 | 1,23 | +2,43 % | |||
XOMA ROYALTY | 25,800 | 0,52 | +2,02 % | 0,54 | 03.01.2025 | |
STRYKER | 352,30 | 3,12 | +0,89 % | 0,84 | 31.12.2024 | |
BIOGEN | 143,80 | 0,00 | 0,00 % | |||
QIAGEN | 43,015 | 0,00 | 0,00 % | |||
MYRIAD GENETICS | 12,800 | 0,00 | 0,00 % | |||
TRANSGENE | 0,701 | 0,00 | 0,00 % | |||
INOVIO PHARMACEUTICALS | 1,720 | 0,00 | 0,00 % |